Trial intelligence / Profile preview

Pregabalin for Opioid Reduction in Spinal Fusion

NCT03031340Phase 3Terminated

Sponsor
Montefiore Medical Center
Start
May 2012
Primary completion
Sep 2012
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of pregabalin in postoperative pain, sponsored by Montefiore Medical Center. Primary endpoint: Postoperative Opioid Requirement at 48 hours. Started May 2012; status: terminated.

02

Drugs

pregabalin
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03031340.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03031340.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call